Literature DB >> 33381202

Traditional Chinese Medicine for Essential Hypertension: A Clinical Evidence Map.

Yan Zhang1,2,3, Biqing Wang4,2,3, Chunxiao Ju4,2,3, Lu Liu4,2,3, Ying Zhu4,2,3, Jun Mei2,3, Yue Liu5,3, Fengqin Xu2,3.   

Abstract

We systematically retrieved and summarised clinical studies on traditional Chinese medicine (TCM) for the prevention and treatment of essential hypertension (EH) using the evidence map. We aimed to explore the evidence distribution, identify gaps in evidence, and inform on future research priorities. Clinical studies, systematic reviews, guidelines, and pathway studies related to TCM for the prevention and treatment of EH, published between January 2000 and December 2019, were included from databases CNKI, WanFang Data, VIP, PubMed, Embase, and Web of Science. The distribution of evidence was analysed using text descriptions, tables, and graphs. A total of 9,403 articles were included, including 5,920 randomised controlled studies (RCTs), 16 guidelines, expert consensus and path studies, and 139 systematic reviews (SRs). The articles publishing trend increased over time. This study showed that the intervention time of TCM was concentrated at 4-8 weeks, mainly through Chinese herbal medicine (CHM) for the prevention and treatment of elderly hypertension and the complications. A Measurement Tool to Assess Systematic Reviews (AMSTAR) scores of the included reviews ranged from 2 to 10. Most of the SRs had a potentially positive effect (n = 120), mainly in 5-8 score. Primary studies and SRs show potential benefits of TCM in lowering blood pressure, lowering the TCM syndrome and symptom differentiation scores (TCM-SSD scores), improving the total effective rate, and reducing the adverse events. The adjunctive effect of TCM on improving the total effective rate, lowering the blood pressure, lowering the TCM-SSD scores, and lowering the adverse effects was only supported by low-quality evidence in this research. The evidence map was used to show the overall research on TCM for the treatment of EH; however, due to the existing problems of the primary studies, the current research conclusion needs further research with higher quality and standardisation.
Copyright © 2020 Yan Zhang et al.

Entities:  

Year:  2020        PMID: 33381202      PMCID: PMC7765725          DOI: 10.1155/2020/5471931

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  45 in total

1.  Blood-Letting Therapy for Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Xing-Jiang Xiong; Peng-Qian Wang; Sheng-Jie Li
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

2.  The quality analysis of literature retrievals of systematic reviews for traditional Chinese medicine.

Authors:  Min Chen; Yang Xiao; Yuqi Liu; Yuanling Peng; Jia He; Yonggang Zhang; Liang Du
Journal:  J Evid Based Med       Date:  2015-02

3.  Efficacy and safety of Chinese herbal medicine Xiao Yao San in hypertension: A systematic review and meta-analysis.

Authors:  Xingjiang Xiong; Pengqian Wang; Lian Duan; Wei Liu; Fuyong Chu; Shengjie Li; Xiaoke Li; Kelei Su; Hu You; Yanwei Xing
Journal:  Phytomedicine       Date:  2019-01-29       Impact factor: 5.340

4.  Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010.

Authors:  Fangjian Guo; Di He; Wei Zhang; R Grace Walton
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

5.  Acupuncture therapy for essential hypertension: a network meta-analysis.

Authors:  Xiaodong Tan; Yujing Pan; Wei Su; Shaoyu Gong; Hongjun Zhu; Hao Chen; Shu Lu
Journal:  Ann Transl Med       Date:  2019-06

6.  Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study.

Authors:  Pei-Rung Yang; Wei-Tai Shih; Yen-Hua Chu; Pau-Chung Chen; Ching-Yuan Wu
Journal:  BMC Complement Altern Med       Date:  2015-06-06       Impact factor: 3.659

Review 7.  The effect of Chinese herbal medicine Jian Ling Decoction for the treatment of essential hypertension: a systematic review.

Authors:  Xingjiang Xiong; Pengqian Wang; Xiaoke Li; Yuqing Zhang
Journal:  BMJ Open       Date:  2015-02-04       Impact factor: 2.692

8.  Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer.

Authors:  Meisser Madera Anaya; Juan Victor Ariel Franco; Mónica Ballesteros; Ivan Solà; Gerard Urrútia Cuchí; Xavier Bonfill Cosp
Journal:  Cancer Manag Res       Date:  2018-12-24       Impact factor: 3.989

9.  Zhen gan xi feng decoction, a traditional chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Bo Feng; Wei Liu; Lian Duan; Ao Gao; Haixia Li; Jizheng Ma; Xinliang Du; Nan Li; Pengqian Wang; Kelei Su; Fuyong Chu; Guohao Zhang; Xiaoke Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

10.  Outcome measures of chinese herbal medicine for hypertension: an overview of systematic reviews.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-24       Impact factor: 2.629

View more
  3 in total

Review 1.  Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence Map.

Authors:  Ying Wang; Zelei Dai; Qin Wang; Ying He; Yalan Peng; Miaomiao Wu; Haiqi Song; Long Ma; Yonggang Zhang; Nian Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

Review 2.  Treatment of Lung Cancer with Orally Administered Chinese Herbal Medicine: An Evidence Map between 1970-2020.

Authors:  Yue-Rong Gui; Ying Zhang; Xue-Qian Wang; Bing-Jie Fan; Jing-Lei Li; Lan-Xin Zhang; Fen Fan; Kang-di Cao; Xiao-Gang Zhang; Wei Hou
Journal:  Chin J Integr Med       Date:  2022-03-03       Impact factor: 2.626

3.  Effectiveness and safety of Yufeng Ningxin for the treatment of essential hypertension: A protocol for systematic review and meta-analysis.

Authors:  Mingyan Huang; Linzi Long; Mi Deng; Zikai Yu; Hua Qu; Ling Tan; Yuxuan Peng; Changgeng Fu
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.